Patterns of Anthracycline‐Based Chemotherapy‐Induced Adverse Drug Reactions and Their Impact on Relative Dose Intensity among Women with Breast Cancer in …
DA Gadisa, M Assefa, GM Tefera… - Journal of Oncology, 2020 - Wiley Online Library
Background. The breast cancer chemotherapy leads to diverse aspects of noxious or
unintended adverse drug reactions (ADRs) that cause the relative dose intensity (RDI) …
unintended adverse drug reactions (ADRs) that cause the relative dose intensity (RDI) …
[HTML][HTML] Hematological Toxicity during Breast Cancer Chemotherapy in Pointe-Noire (Congo Brazzaville)
CFS Ngatali, AFBL Liboko, Y Mabiala… - Journal of Cancer …, 2022 - scirp.org
Introduction: The objective of our study was to determine the prevalence of hematological
toxicity during breast cancer chemotherapy. Patients and Methods: This was a cross …
toxicity during breast cancer chemotherapy. Patients and Methods: This was a cross …
[PDF][PDF] AN UPDATE ON TREATMENT PROTOCOLS IN BREAST CARCINOMA
S Tyagi, P Khanduri, S Singh - iqac.quantumuniversity.edu.in
The treatment protocols of carcinoma is dependent upon disease staging, tumor
characteristics such asmetastasis, status of molecular markers like ER, PR, and HER2 new …
characteristics such asmetastasis, status of molecular markers like ER, PR, and HER2 new …
[PDF][PDF] Research Article Patterns of Anthracycline-Based Chemotherapy-Induced Adverse Drug Reactions and Their Impact on Relative Dose Intensity among Women …
Background. e breast cancer chemotherapy leads to diverse aspects of noxious or
unintended adverse drug reactions (ADRs) that cause the relative dose intensity (RDI) …
unintended adverse drug reactions (ADRs) that cause the relative dose intensity (RDI) …